Great Lakes Advisors’s RxSight RXST Stock Holding History

Great Lakes Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-179,345	Closed	-$6.17M	–	857
2024 Q4	$6.17M	Sell	179,345 -5,801	-3%	-$262K	0.05%	269
2024 Q3	$9.15M	Sell	185,146 -9,068	-5%	-$465K	0.08%	213
2024 Q2	$11.7M	Sell	194,214 -10,936	-5%	-$625K	0.1%	184
2024 Q1	$10.6M	Buy	205,150 +1,135	+0.6%	+$55.7K	0.09%	202
2023 Q4	$8.23M	Buy	+204,015	New	+$5.98M	0.08%	226

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Great Lakes Advisors's RXST Position: Q1 2025 in Review

Great Lakes Advisors sold out of RxSight (RXST) in Q1 2025, closing a stake of 179,345 shares — an estimated $6.17M sold.

Great Lakes Advisors first reported a position in RXST in Q4 2023 and held it in 5 quarters. The position peaked at $11.7M in Q2 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

Great Lakes Advisors reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
Great Lakes Advisors sold 179,345 RxSight shares in Q1 2025, an estimated $6.17M.
Great Lakes Advisors first reported a position in RxSight in Q4 2023 and held it in 5 quarters.
Great Lakes Advisors's RxSight position peaked at $11.7M in Q2 2024.
192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Great Lakes Advisors's 13F filing for Q1 2025, filed 16 May 2025.